Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
CHMP recommendation
Pharma
Europe's CHMP turns down Lilly's Alzheimer's drug Kisunla
Lilly will seek a re-examination of the decision, which found that the benefits of the treatment don't outweigh the safety risks.
Zoey Becker
Mar 28, 2025 11:36am
CHMP again backs Leqembi amid flurry of approval recommendations
Feb 28, 2025 10:30am
CHMP endorses host of new meds, reevaluates Leqembi
Jan 31, 2025 11:16am
EU regulators endorse meds from BMS, J&J, Eisai and more
Nov 15, 2024 10:05am
Europe's CHMP backs Novo's FDA-rejected hemophilia treatment
Oct 18, 2024 11:27am
Apellis hit with yet another eye drug snub in Europe
Sep 20, 2024 10:06am
